ERK is described to affect cell death via modulation of the Bcl-2 family60, which only plays a relative minor role in GB61–64 compared to, for example, in leukaemia, where blocking Bcl-2 can be sufficient to induce apoptosis65. This evidence concerns the gene BCL2 and leukemia.